Literature DB >> 25540881

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke.

Michael E Nassif1, Anjan Tibrewala2, David S Raymer1, Adam Andruska2, Eric Novak1, Justin M Vader1, Akinobu Itoh3, Scott C Silvestry3, Gregory A Ewald1, Shane J LaRue4.   

Abstract

BACKGROUND: Stroke is a significant complication in patients supported with continuous-flow left ventricular assist devices (CF-LVAD) and hypertension is a significant risk factor for stroke, but the association between blood pressure and stroke in LVAD patients is not well characterized.
METHODS: We identified 275 consecutive patients who survived implant hospitalization between January 2005 and April 2013. Patients were grouped according to systolic blood pressure (SBP) as above a median and below a median of 100 mm Hg by their averaged systolic blood pressure during the 48 hours before discharge from implantation hospitalization. The groups were compared for the primary outcome of time to stroke.
RESULTS: The above-median SBP group had mean SBP of 110 mm Hg and the below-median SBP group had mean SBP of 95 mm Hg. There were no significant between-group differences in body mass index, smoking, vascular disease, hypertension, atrial fibrillation, or prior stroke. During a mean follow-up of 16 months, stroke occurred in 16% of the above-median SBP group vs in 7% of the below-median SBP group (hazard ratio, 2.38; 95% confidence interval, 1.11-5.11), with a similar proportion of hemorrhagic and ischemic strokes in each group. In Cox proportional hazard models adjusting for age, diabetes, or prior stroke, the hazard ratio remained statistically significant. SBP as a continuous variable predictor of stroke had an area under the curve of 0.64 in a receiver operating characteristic curve analysis.
CONCLUSIONS: In this large, CF-LVAD cohort, elevated SBP was independently associated with a greater risk of subsequent stroke. These results identify management of hypertension as a potential modifiable risk factor for reducing the incidence of stroke in patients supported by CF-LVAD.
Copyright © 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  continuous flow; hypertension; left ventricular assist device; stroke; systolic blood pressure

Mesh:

Year:  2014        PMID: 25540881      PMCID: PMC4402112          DOI: 10.1016/j.healun.2014.09.042

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  15 in total

1.  Effects of continuous flow left ventricular assist device support on microvascular endothelial function.

Authors:  Xiaoying Lou; Danielle L Templeton; Ranjit John; Donald R Dengel
Journal:  J Cardiovasc Transl Res       Date:  2011-09-20       Impact factor: 4.132

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors.

Authors:  R L Sacco; E J Benjamin; J P Broderick; M Dyken; J D Easton; W M Feinberg; L B Goldstein; P B Gorelick; G Howard; S J Kittner; T A Manolio; J P Whisnant; P A Wolf
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

4.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Authors:  David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

5.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

6.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

7.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

8.  Assessment of arterial blood pressure during support with an axial flow left ventricular assist device.

Authors:  Timothy J Myers; Mathius Bolmers; Igor D Gregoric; Biswajit Kar; O H Howard Frazier
Journal:  J Heart Lung Transplant       Date:  2009-03-19       Impact factor: 10.247

9.  The effect of Ventricular Assist Devices on cerebral autoregulation: A preliminary study.

Authors:  Judith Bellapart; Gregory S Chan; Yu-Chieh Tzeng; Philip Ainslie; Adrian G Barnett; Kimble R Dunster; Rob Boots; John F Fraser
Journal:  BMC Anesthesiol       Date:  2011-02-22       Impact factor: 2.217

10.  The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure.

Authors:  Katherine Lietz; Kevin Brown; Syed S Ali; Monica Colvin-Adams; Andrew J Boyle; David Anderson; Alan D Weinberg; Leslie W Miller; Soon Park; Ranjit John; Ronald M Lazar
Journal:  J Thorac Cardiovasc Surg       Date:  2009-04       Impact factor: 5.209

View more
  23 in total

1.  HeartMate 3-a "Step" in the right direction.

Authors:  Juglans Alvarez; Vivek Rao
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist Devices.

Authors:  Rayan Yousefzai; Michela Brambatti; Hao A Tran; Rachel Pedersen; Oscar Ö Braun; Tina Baykaner; Roxana Ghashghaei; Nasir Z Sulemanjee; Omar M Cheema; Matthew Rappelt; Carmela Baeza; Abdulaziz Alkhayyat; Yang Shi; Victor Pretorius; Barry Greenberg; Eric Adler; Vinay Thohan
Journal:  ASAIO J       Date:  2020-04       Impact factor: 2.872

Review 3.  Hypertension and Stroke in Patients with Left Ventricular Assist Devices (LVADs).

Authors:  Joshua Z Willey; Amelia K Boehme; Francesco Castagna; Melana Yuzefpolskaya; A Reshad Garan; Veli Topkara; Paolo C Colombo
Journal:  Curr Hypertens Rep       Date:  2016-02       Impact factor: 5.369

Review 4.  Mechanical circulatory support in children: past, present and future.

Authors:  Svetlana B Shugh; Kyle W Riggs; David L S Morales
Journal:  Transl Pediatr       Date:  2019-10

5.  Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices.

Authors:  Nastasya Volkovicher; Chitaru Kurihara; Andre Critsinelis; Masashi Kawabori; Tadahisa Sugiura; Marcos Manon; Andrew B Civitello; Jeffrey A Morgan
Journal:  J Artif Organs       Date:  2018-01-25       Impact factor: 1.731

Review 6.  Blood pressure management in mechanical circulatory support.

Authors:  Mosi K Bennett; Sirtaz Adatya
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

7.  Impact and Measurement of Blood Pressure During Continuous Flow Left Ventricular Assist Device Support: The Pressure Is On!

Authors:  Omar Saeed; Ulrich P Jorde
Journal:  ASAIO J       Date:  2019-02       Impact factor: 2.872

Review 8.  Prevention and Treatment of Thrombotic and Hemorrhagic Complications in Patients Supported by Continuous-Flow Left Ventricular Assist Devices.

Authors:  Renzo Y Loyaga-Rendon; Milena Jani; David Fermin; Jennifer K McDermott; Diane Vancamp; Sangjin Lee
Journal:  Curr Heart Fail Rep       Date:  2017-12

9.  Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: An Interagency Registry for Mechanically Assisted Circulatory Support analysis.

Authors:  Jennifer A Cowger; Palak Shah; Francis D Pagani; Gillan Grafton; John Stulak; Themistokles Chamogeorgakis; David Lanfear; Hassan Nemeh; Sean Pinney
Journal:  J Heart Lung Transplant       Date:  2019-11-26       Impact factor: 10.247

10.  Cerebrovascular Events After Continuous-Flow Left Ventricular Assist Devices.

Authors:  Pouya Tahsili-Fahadan; David R Curfman; Albert A Davis; Noushin Yahyavi-Firouz-Abadi; Lucia Rivera-Lara; Michael E Nassif; Shane J LaRue; Gregory A Ewald; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.